MRC2 and prostate carcinoma: In addition to these cancer forms, uPARAP displays a strong upregulation in the stromal compartment of several cancers of epithelial origin, including breast [60–62], head and neck [30] and prostate cancer, where even a mixed tumor-stroma expression has been reported for the latter [63, 64].